Byram W. Bridle

Department of Pathobiology, University of Guelph

Research Area

Biography

Byram W. Bridle has not added Biography.
If you are Byram W. Bridle and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 17	2021

Other Publications

Article	Year
Rat genotype influences quantitative and qualitative aspects of xenogeneic immune response to pig blood mononuclear cells. Xenotransplantation\| PubMed ID: 16768723	2006
T lymphocyte subpopulations diverge in commercially raised chickens. Canadian journal of veterinary research = Revue canadienne de recherche veterinaire\| PubMed ID: 16850940	2006
Deviation of xenogeneic immune response and bystander suppression in rats fed porcine blood mononuclear cells. Transplant immunology\| PubMed ID: 17493529	2007
Steering orally induced deviation of xenogeneic immunity with exogenous cytokines in rats fed porcine proteins. Transplant immunology\| PubMed ID: 19748586	2009
Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 22760544	2012
Maraba virus as a potent oncolytic vaccine vector. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 24322333	2014
Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost Vaccination. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 27183620	2016
Replication and Oncolytic Activity of an Avian Orthoreovirus in Human Hepatocellular Carcinoma Cells. Viruses\| PubMed ID: 28441762	2017
Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes. Immunology\| PubMed ID: 28621843	2017
Enhancing Immune Responses to Cancer Vaccines Using Multi-Site Injections. Scientific reports\| PubMed ID: 28814733	2017
Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission. Endocrine-related cancer\| PubMed ID: 28912377	2017
Maraba virus-vectored cancer vaccines represent a safe and novel therapeutic option for cats. Scientific reports\| PubMed ID: 29146945	2017
Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 29311387	2018
Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer. Molecular therapy. Methods & clinical development\| PubMed ID: 29556508	2018
Use of Precision-Cut Lung Slices as an Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic Therapy. Molecular therapy. Methods & clinical development\| PubMed ID: 30112421	2018
Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 30206160	2019
Development and applications of oncolytic Maraba virus vaccines. Oncolytic virotherapy\| PubMed ID: 30538968	2018
Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies. Molecular therapy. Methods & clinical development\| PubMed ID: 30788384	2019
Myeloid Cells during Viral Infections and Inflammation. Viruses\| PubMed ID: 30791481	2019
AAV-mediated expression of 3TSR inhibits tumor and metastatic lesion development and extends survival in a murine model of epithelial ovarian carcinoma. Cancer gene therapy\| PubMed ID: 31160686	2020
Quantifying Antibody Responses Induced by Antigen-Agnostic Immunotherapies. Molecular therapy. Methods & clinical development\| PubMed ID: 31388514	2019
Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 31486039	2020
SR9009 administered for one day after myocardial ischemia-reperfusion prevents heart failure in mice by targeting the cardiac inflammasome. Communications biology\| PubMed ID: 31602405	2019
Optimized Pre-Clinical Grade Production of Two Novel Lentiviral Vector Pseudotypes for Lung Gene Delivery. Human gene therapy\| PubMed ID: 32000531	2020
Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning. Journal for immunotherapy of cancer\| PubMed ID: 32792361	2020
Tumour vasculature: Friend or foe of oncolytic viruses? Cytokine & growth factor reviews\| PubMed ID: 32893095	2020
AAV Vectored Immunoprophylaxis for Filovirus Infections. Tropical medicine and infectious disease\| PubMed ID: 33182447	2020
Type I Interferon α/β Receptor-Mediated Signaling Negatively Regulates Antiviral Cytokine Responses in Murine Bone-Marrow-Derived Mast Cells and Protects the Cells from Virus-Induced Cell De... International journal of molecular sciences\| PubMed ID: 33261178	2020
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models. Molecular therapy oncolytics\| PubMed ID: 33614913	2021
Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils. International journal of molecular sciences\| PubMed ID: 33946935	2021
The Role of Type I Interferon Signaling in Regulating Cytokine Production and Cell Survival in Bone Marrow-Derived Macrophages. Viral immunology\| PubMed ID: 34097550	2021